- Home
- ICUCW vs SIGA Comparison
ICUCW vs SIGA Comparison
Compare ICUCW & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUCW
- SIGA
- Stock Information
- Founded
- ICUCW N/A
- SIGA 1995
- Country
- ICUCW United States
- SIGA United States
- Employees
- ICUCW 18
- SIGA N/A
- Industry
- ICUCW Biotechnology: Pharmaceutical Preparations
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- ICUCW Health Care
- SIGA Health Care
- Exchange
- ICUCW Nasdaq
- SIGA Nasdaq
- Market Cap
- ICUCW N/A
- SIGA 515.1M
- IPO Year
- ICUCW 2021
- SIGA 1997
- Fundamental
- Price
- ICUCW $0.04
- SIGA $8.30
- Analyst Decision
- ICUCW
- SIGA
- Analyst Count
- ICUCW 0
- SIGA 0
- Target Price
- ICUCW N/A
- SIGA N/A
- AVG Volume (30 Days)
- ICUCW N/A
- SIGA 416.9K
- Earning Date
- ICUCW N/A
- SIGA 11-06-2025
- Dividend Yield
- ICUCW N/A
- SIGA 7.23%
- EPS Growth
- ICUCW N/A
- SIGA N/A
- EPS
- ICUCW N/A
- SIGA 1.14
- Revenue
- ICUCW N/A
- SIGA $179,639,422.00
- Revenue This Year
- ICUCW N/A
- SIGA N/A
- Revenue Next Year
- ICUCW N/A
- SIGA $115.06
- P/E Ratio
- ICUCW N/A
- SIGA $7.28
- Revenue Growth
- ICUCW N/A
- SIGA 3.86
- 52 Week Low
- ICUCW N/A
- SIGA $4.95
- 52 Week High
- ICUCW N/A
- SIGA $9.62
- Technical
- Relative Strength Index (RSI)
- ICUCW 52.56
- SIGA 44.81
- Support Level
- ICUCW $0.03
- SIGA $8.00
- Resistance Level
- ICUCW $0.03
- SIGA $8.53
- Average True Range (ATR)
- ICUCW 0.01
- SIGA 0.31
- MACD
- ICUCW 0.00
- SIGA -0.07
- Stochastic Oscillator
- ICUCW 62.99
- SIGA 20.54
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.